Asia Pacific Head and Neck Cancer Diagnostics Market – share, Outlook, Trends, Size and Forecast (2024 – 2032)

Head and Neck cancer diagnostics market deals various types of malignant tumours grown in and around head and neck which are collectively known as head and neck cancers. Most of the cancers are started in the squamous cells that line the moist mucosal surfaces of the mouth, throat, and nose identified as carcinoma. The initial points are in oral cavities, nasal cavities, larynx, salivary glands, pharynx and paranasal sinuses. Prevalence of target diseases, ageing and geriatric population, has been boosting the nuclear medicine market to handle many industries.

Asia-Pacific Head and Neck Cancer Diagnostics Market Size & Growth:

Asia-Pacific head and neck cancer diagnostics market is projected to reach $ 18.106 billion by 2024 with CAGR between 12 to 13% from $ 9.132 billion in 2017 during forecast 2018-2014. The critical parameters promoting the market growth are prevalence in target and chronic diseases, rise in geriatric population all over the world and healthcare initiatives by government, advancements in treatment modes and advanced diagnostic technologies and inclination in healthcare expenditure of people and so on. However, the high cost of treatment modes and lack of awareness about the cancers are hampering the market growth.

Asia-Pacific Head and Neck Cancer Diagnostics Market Share:

Asia-Pacific head and neck cancer diagnostics market is categorised into diagnostics imaging equipment, endoscopy screening equipment, bioscopy screening tests, blood tests and dental diagnostics methods. By diagnostic imaging, the market is classified as PET, CT, MRI, X-RAY, and barium swallow test. This diagnostic imaging carries the significant share in the market due to the advancements in the treatment processes. By endoscopy screening equipment, the market is categorised into pharyngoscopy, laryngoscopy, and panendoscopy. Among bioscopy screening tests the market is segmented into incisional biopsy, fine needle aspiration, biopsy and HPV testing. Blood tests segment includes total cell count tests, liver function test, and EBV antibody measurement. Dental diagnostics method is based on fluorescence visualisation, toluidine blue dye-based method, acetic acid rinse method and brush biopsy. By geography, APAC is expected to be the dominant one and fastest growing market due to the emerging economies and APAC is holding the highest CAGR rate during the forecast period due to demand for developed healthcare infrastructure and advanced technologies.

Asia-Pacific Head and Neck Cancer Diagnostics Market Trends:

• Philips acquired Spectranetics Corporation to accelerate the expansion of image-guided therapy devices to treat various types of cancers.
• Philips has launched new diagnostic equipment that has been developed as designed at research and development centres in India and manufactured at Pune.
• GE Healthcare and Roche diagnostics come together to develop industry-first software integrating in-vivo and in-vitro diagnostics data with latest clinical research for improved patient outcomes.
• GE Healthcare was acquired by purifying, and GE Healthcare provides transformational medical technologies and services.

Asia-Pacific Head and Neck Cancer Diagnostics Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players are:

• Phillips health care
• Siemens Healthcare
• GE Healthcare
• Shimadzu Corporation
• Varian medical systems